-
VIDEO TRANSCRIPT: Looping video of falling confetti and two QWO vials sitting on a white table.
A Cutting Edge Treatment for Cellulite Without the Cutting
Now Available
Qwo® may be a game changer for your aesthetics practice.1,2 It is the first and only FDA-approved injectable treatment for moderate to severe cellulite in the buttocks of adult women.
-
Visible Results You Can Get Behind
Qwo® provides an opportunity to help appropriate patients who are bothered by their moderate to severe cellulite in the buttocks.1
Primary Efficacy Endpoint: Two-grade or better improvement measured by both physician and patient rated photonumeric cellulite severity score assessments occurred in 7.6% (P=.006) of patients.3 Phase 3 subject images. Individual results may vary.
-
Cellulite Affects Approximately 90% of Women4
But are they ready to talk about it? In a recent online Harris Poll conducted with over 2,000 women with cellulite (ages 18-59), most women (89%) indicated that they are ready to talk to you about their cellulite.5
Paid models. Not actual patient.
-
VIDEO TRANSCRIPT: Looping video depicting a needle penetrating dermis.
Perceived Mechanism of Action
Enzymatic Subcision & Remodeling™
While the exact mechanism for the treatment of moderate to severe cellulite is unknown, Qwo® is believed to initiate a process called Enzymatic Subcision and Remodeling (ESR™).1,2
As seen on
Carousel items
The Opportunity for Your Practice
The QWO Difference:

First and only FDA-approved injectable treatment for moderate to severe cellulite in the buttocks of adult women

Visible results 28 days after the third treatment (21 days apart).1,3*

In the clinical trials, no post-treatment downtime was required.6

The exact mechanism for the treatment of moderate to severe cellulite is unknown.1
*In clinical trials, efficacy was assessed at Day 71. Individual results may vary.
“I am thrilled there is now an FDA-approved injectable treatment option for cellulite to offer to my patients.”
–––– Anne Chapas, MD
Mechanism of Action Video